Nima Sharifi, M.D., Cleveland Clinic Lerner Research Institute (IMAGE)
Caption
According to new findings published in Science Translational Medicine, Cleveland Clinic researchers, led by Nima Sharifi, M.D., have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer.
Credit
Cleveland Clinic
Usage Restrictions
None
License
Licensed content